Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 154 Pages
Report ld: 4944930
Request Sample
Customized Report
Insulin Safety Pen Needles Market Size(US$)

CAGR 2025-2031
9.2%
Market Size,2031
USD 463
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Insulin Safety Pen Needles market is projected to grow from US$ 256 million in 2024 to US$ 463 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Insulin safety pen needles are single-use, high-safety consumables engineered for insulin pens. Building on conventional pen needles, they integrate safeguards such as hidden tips, automatic retraction, dual locking, and anti-misfire features to reduce needlestick injuries and potential cross-contamination while enhancing puncture smoothness and injection comfort. The design prioritizes ergonomics, biocompatible materials, and manufacturing precision to upgrade safety across both self-administration and clinical settings. As patient education, infection control, and prescribing practices evolve, insulin safety pen needles have become a pivotal link in the insulin delivery value chain, aligning drug-device integration and compliance for home care, outpatient use, and chronic-disease follow-up scenarios.In 2024, global Insulin safety pen needles production reached approximately 635 million units, with an average global market price of around US$ 403.6 per k unit.
With chronic-disease management and infection control being reinforced, safety pen needles that feature protective structures and traceability align with extended prescribing practices and catalyze safety-centric product upgrades. Government standards and quality systems are tightening, while brokerage research highlights structural growth in premium consumables and annual reports from industry leaders emphasize compliance and brand moats—together advancing technology and standards on the supply side. In parallel, long-acting pipelines and diversified injection regimens from pharma create a platform for synergy between safety needles and intelligent delivery systems.Across varied reimbursement and procurement regimes, value realization faces constraints from cost sensitivity and differences in volume-based purchasing rules, calling for clearer evidence linking price to clinical benefit. Patent barriers, regulatory registration, and cross-regional quality harmonization raise entry thresholds, and supply chains face pressure in compliance, traceability, and continuity. Signals from annual reports and regulatory notices indicate stricter audits, making process validation, in-process control, and vigilance management sustained investment areas, with sector consolidation introducing transitional uncertainty.Growing patient self-management and education are shifting preferences toward products that blend safety, comfort, and convenience; standardized safety-injection protocols in primary care and specialty clinics support steady, batch-scale adoption. Digital follow-up and adherence management extend service elements into devices, driving ecosystem combinations of safety pen needles, smart pens, companion consumables, and data platforms. This enhances clinical visibility and compliance records and opens new dimensions for brand differentiation.Safety pen needles impose stringent requirements on medical-grade stainless steel, polypropylene and polycarbonate, elastomers, and silicone-based lubricants; material purity, micro-surface finishing, and lubricant stability directly influence puncture resistance and comfort. Updates reflected in annual reports and government standards elevate certification, traceability, and environmental compliance at the material level. High-quality suppliers gain leverage through robust systems and batch consistency, while leading manufacturers localize and diversify sourcing and use tooling plus automation upgrades to buffer yield from material volatility.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Insulin Safety Pen Needles market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Insulin Safety Pen Needles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Insulin Safety Pen Needles: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Insulin Safety Pen Needles Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Auto-Retractable Safety Pen Needles
1.2.3 Auto-Lock Safety Pen Needles
1.2.4 Manual Safety Pen Needles
1.3 Market Segmentation by Application
1.3.1 Global Insulin Safety Pen Needles Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Safety Pen Needles Revenue Estimates and Forecasts 2020-2031
2.2 Global Insulin Safety Pen Needles Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Insulin Safety Pen Needles Sales Estimates and Forecasts 2020-2031
2.4 Global Insulin Safety Pen Needles Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Insulin Safety Pen Needles Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Insulin Safety Pen Needles Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Auto-Retractable Safety Pen Needles Market Size by Manufacturers
3.5.2 Auto-Lock Safety Pen Needles Market Size by Manufacturers
3.5.3 Manual Safety Pen Needles Market Size by Manufacturers
3.6 Global Insulin Safety Pen Needles Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Insulin Safety Pen Needles Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Insulin Safety Pen Needles Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Insulin Safety Pen Needles Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Insulin Safety Pen Needles Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Insulin Safety Pen Needles Sales and Revenue by Type (2020-2031)
6.4 North America Insulin Safety Pen Needles Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Insulin Safety Pen Needles Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Insulin Safety Pen Needles Sales and Revenue by Type (2020-2031)
7.4 Europe Insulin Safety Pen Needles Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Insulin Safety Pen Needles Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Insulin Safety Pen Needles Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Insulin Safety Pen Needles Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Insulin Safety Pen Needles Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Insulin Safety Pen Needles Sales and Revenue by Type (2020-2031)
9.4 Central and South America Insulin Safety Pen Needles Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Insulin Safety Pen Needles Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Insulin Safety Pen Needles Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Insulin Safety Pen Needles Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Insulin Safety Pen Needles Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Embecta
11.1.1 Embecta Corporation Information
11.1.2 Embecta Business Overview
11.1.3 Embecta Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.1.4 Embecta Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Embecta Insulin Safety Pen Needles Sales by Product in 2024
11.1.6 Embecta Insulin Safety Pen Needles Sales by Application in 2024
11.1.7 Embecta Insulin Safety Pen Needles Sales by Geographic Area in 2024
11.1.8 Embecta Insulin Safety Pen Needles SWOT Analysis
11.1.9 Embecta Recent Developments
11.2 MTD Group
11.2.1 MTD Group Corporation Information
11.2.2 MTD Group Business Overview
11.2.3 MTD Group Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.2.4 MTD Group Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 MTD Group Insulin Safety Pen Needles Sales by Product in 2024
11.2.6 MTD Group Insulin Safety Pen Needles Sales by Application in 2024
11.2.7 MTD Group Insulin Safety Pen Needles Sales by Geographic Area in 2024
11.2.8 MTD Group Insulin Safety Pen Needles SWOT Analysis
11.2.9 MTD Group Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Corporation Information
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.3.4 Novo Nordisk Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novo Nordisk Insulin Safety Pen Needles Sales by Product in 2024
11.3.6 Novo Nordisk Insulin Safety Pen Needles Sales by Application in 2024
11.3.7 Novo Nordisk Insulin Safety Pen Needles Sales by Geographic Area in 2024
11.3.8 Novo Nordisk Insulin Safety Pen Needles SWOT Analysis
11.3.9 Novo Nordisk Recent Developments
11.4 B. Braun
11.4.1 B. Braun Corporation Information
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.4.4 B. Braun Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 B. Braun Insulin Safety Pen Needles Sales by Product in 2024
11.4.6 B. Braun Insulin Safety Pen Needles Sales by Application in 2024
11.4.7 B. Braun Insulin Safety Pen Needles Sales by Geographic Area in 2024
11.4.8 B. Braun Insulin Safety Pen Needles SWOT Analysis
11.4.9 B. Braun Recent Developments
11.5 Terumo
11.5.1 Terumo Corporation Information
11.5.2 Terumo Business Overview
11.5.3 Terumo Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.5.4 Terumo Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Terumo Insulin Safety Pen Needles Sales by Product in 2024
11.5.6 Terumo Insulin Safety Pen Needles Sales by Application in 2024
11.5.7 Terumo Insulin Safety Pen Needles Sales by Geographic Area in 2024
11.5.8 Terumo Insulin Safety Pen Needles SWOT Analysis
11.5.9 Terumo Recent Developments
11.6 Owen Mumford
11.6.1 Owen Mumford Corporation Information
11.6.2 Owen Mumford Business Overview
11.6.3 Owen Mumford Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.6.4 Owen Mumford Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Owen Mumford Recent Developments
11.7 Bepu Medical
11.7.1 Bepu Medical Corporation Information
11.7.2 Bepu Medical Business Overview
11.7.3 Bepu Medical Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.7.4 Bepu Medical Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bepu Medical Recent Developments
11.8 Ulticare
11.8.1 Ulticare Corporation Information
11.8.2 Ulticare Business Overview
11.8.3 Ulticare Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.8.4 Ulticare Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Ulticare Recent Developments
11.9 Promisemed
11.9.1 Promisemed Corporation Information
11.9.2 Promisemed Business Overview
11.9.3 Promisemed Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.9.4 Promisemed Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Promisemed Recent Developments
11.10 Tianjin Huahong
11.10.1 Tianjin Huahong Corporation Information
11.10.2 Tianjin Huahong Business Overview
11.10.3 Tianjin Huahong Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.10.4 Tianjin Huahong Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Tianjin Huahong Recent Developments
11.11 Suzhou Shali Medical
11.11.1 Suzhou Shali Medical Corporation Information
11.11.2 Suzhou Shali Medical Business Overview
11.11.3 Suzhou Shali Medical Insulin Safety Pen Needles Product Models, Descriptions and Specifications
11.11.4 Suzhou Shali Medical Insulin Safety Pen Needles Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Suzhou Shali Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Insulin Safety Pen Needles Industry Chain
12.2 Insulin Safety Pen Needles Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Insulin Safety Pen Needles Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Insulin Safety Pen Needles Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Insulin Safety Pen Needles Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Insulin Safety Pen Needles Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Insulin Safety Pen Needles market was valued at US$ 273 million in 2025 and is anticipated to reach US$ 501 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 121
USD 2900.00
(Single User License)
The global Insulin Safety Pen Needles market size was US$ 273 million in 2025 and is forecast to reach a readjusted size of US$ 501 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 92
USD 4250.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 273 million in 2025 and is projected to reach US$ 501 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 130
USD 3950.00
(Single User License)
The global Insulin Safety Pen Needles market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-09-08
Pages: 128
USD 3950.00
(Single User License)
The global market for Insulin Safety Pen Needles was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 463 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-09-08
Pages: 93
USD 2900.00
(Single User License)
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 5960 million in 2024 and is forecast to a readjusted size of US$ 8183 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 176
USD 3950.00
(Single User License)
Safety Pen Needles are sterile, single use needles intended for use with pen injector devices for the injection of drugs. Safety pen needles are intended for professional health care users and non-clinical pen users.
Published Date: 2024-01-14
Pages: 107
USD 2900.00
(Single User License)
The global Insulin Safety Pen Needles market was valued at US$ 273 million in 2025 and is anticipated to reach US$ 501 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 121
The global Insulin Safety Pen Needles market size was US$ 273 million in 2025 and is forecast to reach a readjusted size of US$ 501 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 92
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 273 million in 2025 and is projected to reach US$ 501 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 130
The global Insulin Safety Pen Needles market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 463 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-09-08
Pages: 128
The global market for Insulin Safety Pen Needles was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 463 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-09-08
Pages: 93
The global market for Insulin Safety Pen Needles was estimated to be worth US$ 5960 million in 2024 and is forecast to a readjusted size of US$ 8183 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 176
Safety Pen Needles are sterile, single use needles intended for use with pen injector devices for the injection of drugs. Safety pen needles are intended for professional health care users and non-clinical pen users.
Published: 2024-01-14
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now